Interestingly, PsA patients exhibited significantly lower Gal9 levels compared to RA patients in both cohorts; however, lower Gal1 levels were observed in the discovery cohort, but this result was not replicated in the validation cohort. This evidence concerns the gene LGALS1 and rheumatoid arthritis.